References
- Webb MSC, Milner AD, Hiller EJ, Henry RL. Nebulised beclomethasone dipropionate suspension. Arch Dis Child 1986; 61: 1108–1110
- Bisgaard H, Munck SL, Nilsen JP, Petersen W, Ohlsson SV. Inhaled budesonide for the treatment of recurrent wheezing in early childhood. Lancet 1990; 336: 649–651
- Lodrup Carlsen KC, Nikander K, Carisen K-H. How much nebulised budesonide reaches infants and toddlers?. Arch Dis Child 1992; 67: 1077–1079
- De Blic J, Delacourt C, LeBourgeois M, Mahout B, Ostinelli J, Caswell C, Scheinmann P. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. J Allergy Clin Immunol 1996; 98: 14–20
- Wennergren G, Nordvall SL, Hedlin G, Moller C, Asbrink Nilsson E. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers. Acta Pediatr 1996; 85: 183–189
- Van Bever HP, Schuddinck L, Wojciechwski M, Stevens WJ. Aerolized budesonide in asthmatic infants: a double blind study. Pediatr Pulmonol 1990; 9: 177–180
- Ilangovan P, Pedersen S, Godfrey S, Nikander K, Noviski N, Warner JO. Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension. Arch Dis Child 1993; 68: 356–359
- Godfry S, Avital A, Rosler A, Mandelberg A, Uwyyed K. Nebulised budesonide in severe infantile asthma. Lancet 1987; 851–852, ii:
- De Jongste JC, Duiverman EJ. Nebulised budesonide in severe childhood asthma. Lancet 1989, i:
- Volovitz B, Soferman R, Blau H, Nussinovitch M, Varsano I. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes. J Allergy Clin Immunol 1998; 101: 464–469
- Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999; 10:159(9)941–955
- Agertoft L, Pedersen S. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study. Eur Respir J 1997; 10(7)1507–1512
- Doull IJ, Donovan SJ, Wood PJ, Holgate ST. Bloodspot cortisol in mild asthma: the effect of inhaled corticosteroids. Arch Dis Child 1995; 72(4)321–324
- Kemp JP, Skoner DP, Szefler SJ, Wqlton-Bowen K, Cruz-Rivera M, Smith JA. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Ann Allergy Asthma Immunol 1999; 83(3)231–239
- Shapiro G, Mendelson L, Kraemer MJ, Cruz-Rivera M, Walton-Bowen K, Smith JA. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. J Allergy Clin Immunol 1998; 102(5)719–721
- Scott MB, Skoner DP. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma. J Allergy Clin Immunol 1999; 104(4 Pt 2)200–209
- Volovitz B, Amir J, Malik H, Kaushansky A, Varsano I. Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide. N Engl J Med 1993; 329: 1703–1708
- Volovitz B, Bentur L, Finkelstein Y, Mansour Y, Shalitin S, Nussinovitch M, Varsano I. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma oral prednisolone. J Allergy Clin Immunol 1998; 102: 605–609